Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly

Abstract

Background: Mid-life obesity is related to increased risk for overall dementia and Alzheimer´s disease (AD) dementia. In the present work, we aimed to investigate the impact of obesity on brain structure, metabolism, and cerebrospinal fluid (CSF) biomarkers of amyloid (Aβ 1-42) and tau-pathology (total-tau and p-tau) in healthy elderly. Methods: We selected healthy controls from ADNI2 with available CSF AD biomarkers and/or fluorodeoxyglucose (FDG) PET and 3T-MRI. Participants without follow-up or with significant weight loss were excluded from the analyses. Brain cortical thickness (Cth) was evaluated with Freesurfer software and FDG uptake was measured with a surface-based method using both SPM and Freesurfer softwares. We performed regression analyses between FDG uptake, CTh, CSF AD biomarkers levels and BMI and interaction analyses with age by obesity/overweight status. Results: We included 147 individuals (mean age 73.3 years, mean BMI 27.4 Kg/m 2 ). Higher BMI was related to less cortical thickness and higher glucose metabolism in brain areas not typically involved in AD (FWE<0.05), with little overlap between them. There was no association between BMI and any of the CSF core AD biomarkers. The relationship between age and brain metabolism was modified by overweight/obesity status, but not that of age and brain structure or core CSF AD biomarkers. Conclusions: Our data support that obesity has differential effects on brain metabolism and structure independent of an underlying AD pathophysiology in cognitively unimpaired elderly.

Modifiable dementia risk factors and AT(N) biomarkers: findings from the EPAD cohort

“…Given physical activity engagement entails a suite of biological processes, it is likely that many of these molecular targets align with AD neuropathology and therefore require further investigation (de Frutos Lucas et al, 2023). We also found lower BMI was associated with higher levels of p-tau 181 in CSF, where the prevailing evidence seems to indicate an association (Mathys et al, 2017;Bos et al, 2019;Zhang et al, 2022) rather than a lack of association (Pegueroles et al, 2020;Sun et al, 2020). There is considerable literature concerning an age-related risk matrix (Vidoni et al, 2011;Besser et al, 2016;Gottesman et al, 2017;Müller et al, 2017;Bos et al, 2019), a so-called "obesity paradox", where lower BMI in midlife is associated with decreased AD risk while lower BMI in later life is associated with an increased risk.…”

Brain Glucose Metabolism in Health, Obesity, and Cognitive Decline—Does Insulin Have Anything to Do with It? A Narrative Review

“…BGU in this study was evaluated as standardized uptake value (SUV) ratio, using the SUV from pons-vermis area as the reference region. This region is typically used in AD research because it is not affected by hypometabolism [ 92 ]. Another study also using the ADNI database and reporting statistical parametric mapping T-values also reported brain hypermetabolism in obese women, but not in men [ 93 ] ( Table 1 ).…”

The Other Side of Alzheimer’s Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers

“…For example, the increase of free fatty acids, which is common in obesity, contributes to the onset of insulin resistance [102]. In addition, adiposity is a risk factor for diabetes, hypertension, and cardiovascular changes, all conditions contributing themselves to a significantly increased risk of AD [93,103].…”